ArticleJAMA network open2021

Evaluation of the Safety of Calcitonin Gene-Related Peptide Antagonists for Migraine Treatment Among Adults With Raynaud Phenomenon.

Ilana D Breen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.